CE marking transition timelines in Great Britain: 2028 and 2030 expiry dates

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

The current CE transition in the United Kingdom is built around two fixed expiry points. Devices and system or procedure packs relying on EU MDD (93/42/EEC) or AIMDD (90/385/EEC) certificates lose their transitional basis when the relevant provisions expire at 23:59 on 30 June 2028 (reg 19B and reg 30A). Devices relying on EU MDR (2017/745), EU IVDR (2017/746) or EU IVDD (98/79/EC) certificates run until 23:59 on 30 June 2030 (reg 19C, reg 44ZA and reg 44ZB). These dates are set by SI 2023/627, which replaced the original expiry mechanism in reg 1ZA of the UK MDR 2002.

The decisive point for planning is that the usable period is the earlier of the fixed date and the certificate expiry date. A product whose certificate runs out in 2027 stops being placeable in 2027, whatever the statute says about 2028 or 2030. Every runway calculation must therefore combine a statutory date with a commercial date, and the shorter of the two governs. Official guidance is explicit that an expired certificate cannot be relied upon, so there is no grace period once a certificate lapses, and no argument that the statutory window should bridge the gap until renewal is complete.

2. Legal basis

  • UK MDR 2002 (SI 2002/618, as amended): reg 1ZA(1), (2) and (3).
  • SI 2023/627 reg 4: replaces reg 1ZA and provides expressly that reg 19B and reg 30A expire at 23:59 on 30 June 2028; that reg 19C, reg 44ZA and reg 44ZB expire at 23:59 on 30 June 2030; and that certain provisions already expired at 23:59 on 30 June 2023.
  • Official guidance: the GOV.UK document titled ‘Timelines for acceptance of CE marked medical devices in Great Britain (GB)’.

3. Expert insights

Insight one: the earlier-of rule is the most commonly overlooked cost item. The two statutory dates are ceilings, not promises. If a CE certificate expires in 2027 and is not renewed, the British runway for that device terminates in 2027, regardless of the 2028 and 2030 dates. The official guidance states clearly that reliance on an expired certificate is not permitted. For portfolio planning this means the certificate register, not the statute book, is the binding constraint for most companies, and the certificate register is the part that commercial teams forget to check when they plan launches and stock builds for the British market.

Insight two: SI 2023/627 also tightened the conditions of certificate validity. Regulations 6 to 10 add requirements inside reg 19B, reg 19C, reg 30A, reg 44ZA and reg 44ZB: the manufacturer must ensure that the certificate relevant to the conformity assessment has not expired and has not been withdrawn (for example reg 19C(3)(ba) and reg 44ZB(3)(ba)), or that it remains valid under EU MDR Article 120(2) or EU IVDR Article 110(2) (reg 19B(3)(ba), reg 30A(3)(ba) and reg 44ZA(3)(ba)). This is a second gate, independent of the fixed dates. A device can sit comfortably inside the statutory window and still fall out of the transition the moment its certificate is withdrawn or lapses under EU law.

Insight three: the 30 June 2023 date, although past, still matters. Reg 1ZA(3) lists provisions that already expired on 30 June 2023, including reg 19B(4)(5)(8)(9), reg 19C(8)(9), reg 30A(4) to (7), reg 44ZA(4)(5) and reg 44ZB(4)(5). When reconstructing the historical compliance position of a product, for example in a due diligence exercise, an acquisition review or a response to an MHRA information request, these sub-provisions must be checked, because obligations that look alive in a current consolidated text may in fact have carried different content during earlier periods of the transition.

4. Practical recommendations

GRZAN recommends building a British runway ledger for every CE certificate. The fields should include: certificate number, issuing body, the EU law the certificate rests on, certificate expiry date, applicable transition provision, the statutory British expiry point, the effective cut-off date (the earlier of the two), and the status of the renewal plan. The ledger converts a stack of certificates into a single sortable dataset in which every product’s remaining runway can be read directly, sorted by urgency, and reviewed with the notified body pipeline in mind.

The ledger should be maintained jointly by the UKRP and the manufacturer, and updated immediately whenever a certificate status changes: renewal granted, renewal applied for, withdrawal notified, or suspension suspected. Updates should carry a date and a named owner so that the record remains audit-ready. Where the effective cut-off date falls within the next twenty-four months, the ledger should trigger a documented escalation, since renewal lead times at conformity assessment bodies are now long enough that a late start can leave no realistic path before the cut-off arrives.

5. Verification checklist

  • □ The EU law each certificate rests on has been confirmed (MDD / AIMDD / IVDD / MDR / IVDR)
  • □ Certificate expiry dates have been checked and the earlier of the two dates has been taken
  • □ Certificates have been confirmed not expired and not withdrawn (reg 19C(3)(ba) and the like)
  • □ No reliance is placed on provisions that already expired on 30 June 2023
  • □ The British runway ledger has been built and an update owner has been named

Regulatory information verified as of 29 October 2026.

  • Appointment of a UK responsible person (UKRP) and support for signing the letter of authorisation
  • MHRA registration (DORS): end-to-end filing and account lifecycle management
  • Device classification, GMDN code selection and annual registration fee estimates
  • Dual-route design for Great Britain and Northern Ireland, including UK(NI) options
  • Post-market surveillance (PMS) system build, PMSR/PSUR preparation and vigilance reporting
  • Emergency handling of serious incidents and field safety corrective actions (FSCA)
  • Monitoring of UK regulatory change and compliance gap assessments

GRZAN supports manufacturers entering the United Kingdom with UKCA registration pathways and classification strategy, from first route analysis through to registration and post-market obligations. For a structured review of your product portfolio, contact info@grzanglobal.com.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail